INVO Fertility Inc. is a healthcare services fertility company, which is engaged in expanding access to assisted reproductive technology (ART) care to patients in need. The Company’s principal commercial strategy is focused on building, acquiring, and operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, profitable in vitro fertilization (IVF) clinics. The Company has four operational fertility clinics in the United States. The Company is also engaged in the sale and distribution of INVOcell to third-party owned and operated fertility clinics. INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a more connected, intimate, and affordable experience in comparison to other ART treatments.
Company Information
About this company
Key people
Steven M. Shum
Chief Executive Officer, Director
Terah Krigsvold
Chief Financial Officer
Andrea Goren
Chief Business Officer
Daniel Teper
Director
Trent Davis
Independent Director
Rebecca Messina
Independent Director
Barbara A. Ryan
Independent Director
Matthew K. Szot
Independent Director
Click to see more
Key facts
- Shares in issue6.96m
- EPICIVF
- ISINUS44984F8077
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$5.38m
- Employees28
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.